Expert Pitch
University of Michigan

Why have nursing homes been hit harder by the coronavirus, and should you remove your relative?

15-May-2020 12:05 PM EDT, by University of Michigan

ANN ARBOR—Nursing home residents and workers account for about one-third of COVID-19 deaths in the United States, so far, according to media reports.

Sheria Robinson-Lane, a gerontologist and assistant professor at the University of Michigan School of Nursing, is an expert in palliative and long-term care and nursing administration. Her research focuses on the care and support of older adults with cognitive and/or functional disabilities, and on ways older adults adapt to changes in health, particularly how adaptive coping strategies affect health outcomes.

Why is the risk so much greater in nursing homes?

Some of our most vulnerable adults live in nursing homes. Just to qualify for a nursing home stay, whether for short-term rehabilitation or long-term care, you must require 24-hour nursing care. This care is generally necessary as a result of significant injury, like a fractured hip or a traumatic brain injury, or related to worsening of chronic disease.

In general, more than 90% of older adults have at least one chronic disease. More than 70% have at least two chronic diseases. In nursing homes, this number starts to go up significantly. As a result of chronic disease and/or injury, people in nursing homes generally do not have optimal immune system functioning, so it’s a lot easier for them to get sick in general.

When you add to that living and working in close quarters with others, both the folks who live there and the people that take care of them are at risk for infectious diseases. Managing the transmission of infection is nothing new for nursing homes, but the incredibly contagious nature of COVID-19 has made this very challenging to contain within nursing homes. Unfortunately, due to the already weakened state of many of the residents of these facilities, getting sick is often fatal.

How do I decide whether to bring my loved one home to live with me, temporarily?

The choice to place a loved one in a nursing home is a challenging decision that families struggle with from the very beginning. The reality is, the vast majority of people in nursing homes have care needs that cannot be easily met in a home environment.

For others, it’s possible they could successfully transition to a home environment with the right community services in place. Unfortunately, due to COVID-19, many community-based programs are struggling to meet the needs of current clients.

So the primary thing to consider and question to ask when thinking about bringing someone home is, exactly what are the care needs of my loved one, and do we have what we need to effectively manage their care at home?

Other questions to consider:

And, probably the most important question is, do they want to go home with you?

If there have already been COVID cases at the facility where a family member is, and you are comfortable with their care needs at home, it is also important to remember that they may have already been exposed to the virus, and so there should be a plan for in-home quarantine, as well, for 14 days after discharge from the facility. This means thinking about how to keep them isolated from other family members during this time.

Is it safer for my older adult loved one to be in my home than in a nursing home?

The answer here is that it depends. The safest place for any older adult is where they can get all of their care needs met effectively and have the least amount of exposure to COVID-19. Most facilities should have plans in place for socially isolating COVID positive patients. Bringing a loved one home can be the safest place for them if there are no essential workers in the home, appropriate precautions are taken when it is necessary to leave the home (mask-wearing and handwashing), and you are able to meet all of their care needs.

What policies at the state and federal level could lessen the risk for nursing home residents?

Nursing homes are currently very heavily regulated at both the state and federal level. There are specific rules around how infections are tracked within facilities, necessary postings, expectations regarding care and, of course, sanitation.

I think that the primary thing that will lessen the risk for nursing home residents and staff is to significantly expand rapid testing availability. This would make it so much easier for facilities to be able to appropriately quarantine sick residents, limit spread and manage staffing.

Access to adequate PPE also continues to be a concern for direct care staff, so there should be an efficient way for staff to be able to anonymously report concerns to the state so there is no fear of retaliation.




Filters close

Showing results

110 of 4573
Released: 15-Jan-2021 5:40 PM EST
Research Links Social Isolation to COVID-19 Protocol Resistance
Humboldt State University

As health officials continue to implore the public to wear masks and practice social distancing, recent research by Humboldt State University Psychology Professor Amber Gaffney provides key insights into connections between social isolation, conspiratorial thinking, and resistance to COVID-19 protocols.

Newswise: Rapid blood test identifies COVID-19 patients at high risk of severe disease
Released: 15-Jan-2021 5:35 PM EST
Rapid blood test identifies COVID-19 patients at high risk of severe disease
Washington University in St. Louis

Scientists at Washington University School of Medicine in St. Louis have shown that a relatively simple and rapid blood test can predict which patients with COVID-19 are at highest risk of severe complications or death. The blood test measures levels of mitochondrial DNA, which normally resides inside the energy factories of cells. Mitochondrial DNA spilling out of cells and into the bloodstream is a sign that a particular type of violent cell death is taking place in the body.

Released: 15-Jan-2021 2:55 PM EST
COVID-19 deaths really are different. But best practices for ICU care should still apply, studies suggest.
Michigan Medicine - University of Michigan

COVID-19 deaths are indeed different from other lung failure deaths, according to two recent studies, with 56% of COVID-19 patients dying primarily from the lung damage caused by the virus, compared with 22% of those whose lungs fail due to other causes. But, the researchers conclude, the kind of care needed to help sustain people through the worst cases of all forms of lung failure is highly similar, and just needs to be fine-tuned.

Released: 15-Jan-2021 2:50 PM EST
45% of adults over 65 lack online medical accounts that could help them sign up for COVID-19 vaccinations
Michigan Medicine - University of Michigan

As the vaccination of older adults against COVID-19 begins across the country, new poll data suggests that many of them don’t yet have access to the “patient portal” online systems that could make it much easier for them to schedule a vaccination appointment. In all, 45% of adults aged 65 to 80 had not set up an account with their health provider’s portal system.

Released: 15-Jan-2021 1:30 PM EST
New England Journal of Medicine publishes COVID-19 treatment trial results
University of Texas at San Antonio

A clinical trial involving COVID-19 patients hospitalized at UT Health San Antonio and University Health, among roughly 100 sites globally, found that a combination of the drugs baricitinib and remdesivir reduced time to recovery, according to results published Dec. 11 in the New England Journal of Medicine.

Released: 15-Jan-2021 12:40 PM EST
DNA test can quickly identify pneumonia in patients with severe COVID-19, aiding faster treatment
University of Cambridge

Researchers have developed a DNA test to quickly identify secondary infections in COVID-19 patients, who have double the risk of developing pneumonia while on ventilation than non-COVID-19 patients.

Released: 15-Jan-2021 12:30 PM EST
Fight CRC To Present Research Findings on The Impact of COVID-19 on the Colorectal Cancer Community at 2021 GI ASCO
Fight Colorectal Cancer

Fight Colorectal Cancer presents abstract at Gastrointestinal Cancer Symposium highlighting the need to address the barriers and opportunities for care within the colorectal cancer community during the COVID-19 pandemic

Released: 15-Jan-2021 12:25 PM EST
Technion to Award Honorary Doctorate to Pfizer CEO Dr. Albert Bourla
American Technion Society

Israel's Technion will award an honorary doctorate to Pfizer CEO and Chairman Dr. Albert Bourla, for leading the development of the novel vaccine against SARS-CoV-2, the virus that causes COVID-19. The honorary doctorate will be conferred at the Technion Board of Governors meeting in November 2021.

Released: 15-Jan-2021 11:30 AM EST
UW researchers develop tool to equitably distribute limited vaccines
University of Wisconsin-Madison

Researchers at the University of Wisconsin School of Medicine and Public Health and UW Health have developed a tool that incorporates a person’s age and socioeconomic status to prioritize vaccine distribution among people who otherwise share similar risks due to their jobs.


Showing results

110 of 4573

close
1.68383